Logo image
Sign in
Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.
Journal article   Peer reviewed

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.

Benoit Lattuca, David Belardi, Christophe Demattei, Laurent Schmutz, Luc Cornillet, Bertrand Ledermann, Jean-Christophe Macia, Anaïs Iemmi, Richard Gervasoni, François Roubille, …
Journal of Invasive Cardiology
15/07/2018
PMID: 30012889

Abstract

P2Y12 inhibitor acute coronary syndromes clopidogrel coronary artery disease percutaneous coronary intervention pretreatment
Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before percutaneous coronary intervention (PCI) in elective and non-ST segment elevation myocardial infarction (NSTEMI) patients. The aim of this study was to assess outcomes after performing PCI immediately after coronary angiography with an exclusive "on-the-table" P2Y12 inhibitor loading dose, by evaluating ischemic and bleeding complications in unselected patients.
url
Find in HALView

Metrics

1 Record Views

Details

Logo image